Skip to main content
Top
Published in: European Radiology 6/2017

01-06-2017 | Gastrointestinal

Computed tomography features and predictive findings of ruptured gastrointestinal stromal tumours

Authors: Jin Sil Kim, Hyun Jin Kim, Seong Ho Park, Jong Seok Lee, Ah Young Kim, Hyun Kwon Ha

Published in: European Radiology | Issue 6/2017

Login to get access

Abstract

Objectives

To evaluate the CT features of ruptured GISTs and factors that might be predictive of rupture through comparison with CTs taken prior to rupture and CTs of non-ruptured GIST.

Methods

Forty-nine patients with ruptured GIST and forty-nine patients with non-ruptured GIST matched by age, gender and location were included. Clinical data including pharmacotherapy were reviewed. The imaging features were analyzed. Prior CT obtained before rupture were evaluated.

Results

The most common location of ruptured GIST was small bowel with mean size of 12.1 cm. Ruptured GIST commonly showed wall defects, >40 % eccentric necrosis, lobulated shaped, air density in mass, pneumoperitoneum, peritonitis, hemoperitoneum and ascites (p < 0.001–0.030). Twenty-seven of 30 patients with follow up imaging received targeted therapy. During follow-up, thickness of the tumour wall decreased. Increase in size and progression of necrosis were common during targeted therapy (p = 0.017).
Newly developed ascites, peritonitis and hemoperitoneum was more common (p < 0.001–0.036).

Conclusion

Ruptured GISTs commonly demonstrate large size, >40 % eccentric necrosis, wall defects and lobulated shape. The progression of necrosis with increase in size and decreased wall thickness during targeted therapy may increase the risk of rupture. Rupture should be considered when newly developed peritonitis, hemoperitoneum, or ascites are noted during the follow-up.

Key points

Ruptured GISTs demonstrate large size, eccentric necrosis, wall defects, and lobulated shape.
Rupture should be considered when peritonitis or hemoperitoneum/adjacent hematoma newly appears.
Progression of necrosis with increase in size increases the risk of rupture.
Literature
1.
go back to reference Hirota S, Isozaki K, Moriyama Y et al (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577–580CrossRefPubMed Hirota S, Isozaki K, Moriyama Y et al (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577–580CrossRefPubMed
2.
go back to reference Yang J, Yu J, Ma Z, Kang W, Tian S, Ye X (2015) Clinical pathological features and prognosis analysis of gastrointestinal stromal tumor: a series of 558 cases. Zhonghua Wai Ke Za Zhi 53:274–279PubMed Yang J, Yu J, Ma Z, Kang W, Tian S, Ye X (2015) Clinical pathological features and prognosis analysis of gastrointestinal stromal tumor: a series of 558 cases. Zhonghua Wai Ke Za Zhi 53:274–279PubMed
3.
go back to reference Demetri GD, von Mehren M, Blanke CD et al (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472–480CrossRefPubMed Demetri GD, von Mehren M, Blanke CD et al (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472–480CrossRefPubMed
4.
go back to reference Hohenberger P, Ronellenfitsch U, Oladeji O et al (2010) Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour. Br J Surg 97:1854–1859CrossRefPubMed Hohenberger P, Ronellenfitsch U, Oladeji O et al (2010) Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour. Br J Surg 97:1854–1859CrossRefPubMed
5.
go back to reference Baheti AD, Shinagare AB, O'Neill AC et al (2015) MDCT and clinicopathological features of small bowel gastrointestinal stromal tumours in 102 patients: a single institute experience. Br J Radiol 88:20150085CrossRefPubMedPubMedCentral Baheti AD, Shinagare AB, O'Neill AC et al (2015) MDCT and clinicopathological features of small bowel gastrointestinal stromal tumours in 102 patients: a single institute experience. Br J Radiol 88:20150085CrossRefPubMedPubMedCentral
6.
go back to reference Chok AY, Goh BK, Koh YX et al (2015) Validation of the MSKCC Gastrointestinal Stromal Tumor Nomogram and Comparison with Other Prognostication Systems: Single-Institution Experience with 289 Patients. Ann Surg Oncol 22:3597–3605CrossRefPubMed Chok AY, Goh BK, Koh YX et al (2015) Validation of the MSKCC Gastrointestinal Stromal Tumor Nomogram and Comparison with Other Prognostication Systems: Single-Institution Experience with 289 Patients. Ann Surg Oncol 22:3597–3605CrossRefPubMed
7.
go back to reference Cegarra-Navarro MF, de la Calle MA, Girela-Baena E, Garcia-Santos JM, Lloret-Estan F, de Andres EP (2005) Ruptured gastrointestinal stromal tumors: radiologic findings in six cases. Abdom Imaging 30:535–542CrossRefPubMed Cegarra-Navarro MF, de la Calle MA, Girela-Baena E, Garcia-Santos JM, Lloret-Estan F, de Andres EP (2005) Ruptured gastrointestinal stromal tumors: radiologic findings in six cases. Abdom Imaging 30:535–542CrossRefPubMed
8.
go back to reference Pinaikul S, Woodtichartpreecha P, Kanngurn S, Leelakiatpaiboon S (2014) 1189 Gastrointestinal stromal tumor (GIST): computed tomographic features and correlation of CT findings with histologic grade. J Med Assoc Thai 97:1189–1198PubMed Pinaikul S, Woodtichartpreecha P, Kanngurn S, Leelakiatpaiboon S (2014) 1189 Gastrointestinal stromal tumor (GIST): computed tomographic features and correlation of CT findings with histologic grade. J Med Assoc Thai 97:1189–1198PubMed
9.
10.
go back to reference Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S (2002) Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol 33:669–676CrossRefPubMed Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S (2002) Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol 33:669–676CrossRefPubMed
11.
go back to reference Zhou C, Duan X, Zhang X, Hu H, Wang D, Shen J (2015) Predictive features of CT for risk stratifications in patients with primary gastrointestinal stromal tumour. Eur Radiol 1–8 Zhou C, Duan X, Zhang X, Hu H, Wang D, Shen J (2015) Predictive features of CT for risk stratifications in patients with primary gastrointestinal stromal tumour. Eur Radiol 1–8
12.
go back to reference Tirumani SH, Shinagare AB, O’Neill AC, Nishino M, Rosenthal MH, Ramaiya NH (2016) Accuracy and feasibility of estimated tumour volumetry in primary gastric gastrointestinal stromal tumours: validation using semiautomated technique in 127 patients. Eur Radiol 26:286–295CrossRefPubMed Tirumani SH, Shinagare AB, O’Neill AC, Nishino M, Rosenthal MH, Ramaiya NH (2016) Accuracy and feasibility of estimated tumour volumetry in primary gastric gastrointestinal stromal tumours: validation using semiautomated technique in 127 patients. Eur Radiol 26:286–295CrossRefPubMed
13.
go back to reference Rezai P, Pisaneschi MJ, Feng C, Yaghmai V (2013) A radiologist's guide to treatment response criteria in oncologic imaging: Functional, molecular, and disease-specific imaging biomarkers. Am J Roentgenol 201:246–256CrossRef Rezai P, Pisaneschi MJ, Feng C, Yaghmai V (2013) A radiologist's guide to treatment response criteria in oncologic imaging: Functional, molecular, and disease-specific imaging biomarkers. Am J Roentgenol 201:246–256CrossRef
14.
go back to reference Yang TH, Hwang JI, Yang MS et al (2007) Gastrointestinal stromal tumors: computed tomographic features and prediction of malignant risk from computed tomographic imaging. J Chin Med Assoc 70:367–373CrossRefPubMed Yang TH, Hwang JI, Yang MS et al (2007) Gastrointestinal stromal tumors: computed tomographic features and prediction of malignant risk from computed tomographic imaging. J Chin Med Assoc 70:367–373CrossRefPubMed
15.
go back to reference Sandrasegaran K, Rajesh A, Rushing DA, Rydberg J, Akisik FM, Henley JD (2005) Gastrointestinal stromal tumors: CT and MRI findings. Eur Radiol 15:1407–1414CrossRefPubMed Sandrasegaran K, Rajesh A, Rushing DA, Rydberg J, Akisik FM, Henley JD (2005) Gastrointestinal stromal tumors: CT and MRI findings. Eur Radiol 15:1407–1414CrossRefPubMed
16.
go back to reference Lee NK, Kim S, Kim GH et al (2010) Hypervascular subepithelial gastrointestinal masses: CT-pathologic correlation. Radiographics 30:1915–1934CrossRefPubMed Lee NK, Kim S, Kim GH et al (2010) Hypervascular subepithelial gastrointestinal masses: CT-pathologic correlation. Radiographics 30:1915–1934CrossRefPubMed
17.
go back to reference Dematteo RP, Heinrich MC, El-Rifai WM, Demetri G (2002) Clinical management of gastrointestinal stromal tumors: before and after STI-571. Hum Pathol 33:466–477CrossRefPubMed Dematteo RP, Heinrich MC, El-Rifai WM, Demetri G (2002) Clinical management of gastrointestinal stromal tumors: before and after STI-571. Hum Pathol 33:466–477CrossRefPubMed
18.
go back to reference Komatsu Y, Ohki E, Ueno N et al (2015) Safety, efficacy and prognostic analyses of sunitinib in the post-marketing surveillance study of Japanese patients with gastrointestinal stromal tumor. Jpn J Clin Oncol. doi:10.1093/jjco/hyv126 PubMedCentral Komatsu Y, Ohki E, Ueno N et al (2015) Safety, efficacy and prognostic analyses of sunitinib in the post-marketing surveillance study of Japanese patients with gastrointestinal stromal tumor. Jpn J Clin Oncol. doi:10.​1093/​jjco/​hyv126 PubMedCentral
19.
go back to reference Kim R, Emi M, Arihiro K, Tanabe K, Uchida Y, Toge T (2005) Chemosensitization by STI571 targeting the platelet‐derived growth factor/platelet‐derived growth factor receptor‐signaling pathway in the tumor progression and angiogenesis of gastric carcinoma. Cancer 103:1800–1809CrossRefPubMed Kim R, Emi M, Arihiro K, Tanabe K, Uchida Y, Toge T (2005) Chemosensitization by STI571 targeting the platelet‐derived growth factor/platelet‐derived growth factor receptor‐signaling pathway in the tumor progression and angiogenesis of gastric carcinoma. Cancer 103:1800–1809CrossRefPubMed
20.
go back to reference El-Kenawi AE, El-Remessy AB (2013) Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales. Br J Pharmacol 170:712–729CrossRefPubMedPubMedCentral El-Kenawi AE, El-Remessy AB (2013) Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales. Br J Pharmacol 170:712–729CrossRefPubMedPubMedCentral
22.
go back to reference Kim KW, Shinagare AB, Krajewski KM et al (2015) Fluid retention associated with imatinib treatment in patients with gastrointestinal stromal tumor: quantitative radiologic assessment and implications for management. Korean J Radiol 16:304–313CrossRefPubMedPubMedCentral Kim KW, Shinagare AB, Krajewski KM et al (2015) Fluid retention associated with imatinib treatment in patients with gastrointestinal stromal tumor: quantitative radiologic assessment and implications for management. Korean J Radiol 16:304–313CrossRefPubMedPubMedCentral
23.
go back to reference Misawa S, Takeda M, Sakamoto H, Kirii Y, Ota H, Takagi H (2014) Spontaneous rupture of a giant gastrointestinal stromal tumor of the jejunum: a case report and literature review. World J Surg Oncol 12:153CrossRefPubMedPubMedCentral Misawa S, Takeda M, Sakamoto H, Kirii Y, Ota H, Takagi H (2014) Spontaneous rupture of a giant gastrointestinal stromal tumor of the jejunum: a case report and literature review. World J Surg Oncol 12:153CrossRefPubMedPubMedCentral
24.
go back to reference Hamrick-Turner JE, Chiechi MV, Abbitt PL, Ros PR (1992) Neoplastic and inflammatory processes of the peritoneum, omentum, and mesentery: diagnosis with CT. Radiographics 12:1051–1068CrossRefPubMed Hamrick-Turner JE, Chiechi MV, Abbitt PL, Ros PR (1992) Neoplastic and inflammatory processes of the peritoneum, omentum, and mesentery: diagnosis with CT. Radiographics 12:1051–1068CrossRefPubMed
25.
go back to reference (2014) Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25 Suppl 3:iii21–26 (2014) Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25 Suppl 3:iii21–26
Metadata
Title
Computed tomography features and predictive findings of ruptured gastrointestinal stromal tumours
Authors
Jin Sil Kim
Hyun Jin Kim
Seong Ho Park
Jong Seok Lee
Ah Young Kim
Hyun Kwon Ha
Publication date
01-06-2017
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 6/2017
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-016-4515-z

Other articles of this Issue 6/2017

European Radiology 6/2017 Go to the issue